Edition:
United Kingdom

Erytech Pharma SA (ERYP.PA)

ERYP.PA on Paris Stock Exchange

6.10EUR
19 Jul 2019
Change (% chg)

€-0.15 (-2.40%)
Prev Close
€6.25
Open
€6.24
Day's High
€6.24
Day's Low
€6.10
Volume
22,143
Avg. Vol
28,524
52-wk High
€9.86
52-wk Low
€5.61

About

Erytech Pharma SA, also known as ERYTECH Pharma, is a France-based biopharmaceutical company developing medicinal products mainly in oncology, hematology and immunology fields of business. The Company offers ESY-ASP (GRASPA), a medicinal product consisting of L-Asparaginase entrapped into human homologous red blood cells. The... (more)

Overall

Beta: 0.86
Market Cap(Mil.): €284.01
Shares Outstanding(Mil.): 11.74
Dividend: --
Yield (%): --

Financials

  ERYP.PA Industry Sector
P/E (TTM): -- 69.41 32.67
EPS (TTM): -3.20 -- --
ROI: -- 8.94 14.49
ROE: -- 10.07 15.79

BRIEF-Erytech Announces Immune Modulation Strategic Collaboration With SQZ Biotechnologies

* ERYTECH ANNOUNCED ON MONDAY IT HAS ENTERED INTO AN AGREEMENT WITH SQZ BIOTECHNOLOGIES TO ADVANCE NOVEL RBC-BASED THERAPEUTICS FOR IMMUNE MODULATION

25 Jun 2019

BRIEF-Erytech Pharma Presents New Erymethionase Preclinical Findings

* ERYTECH SAID ON MONDAY IT PRESENTED NEW ERYMETHIONASE PRECLINICAL FINDINGS AT 2019 AACR ANNUAL MEETING

02 Apr 2019

BRIEF- Erytech Pharma FY Total Operating Loss Widens To 43.6 Million Euros

* ANNOUNCED ON MONDAY, ERYTECH PROVIDES BUSINESS UPDATE AND REPORTS FINANCIAL RESULTS FOR FULL YEAR 2018

12 Mar 2019

Earnings vs. Estimates